Surgical management of recurrent giant retroperitoneal liposarcoma: a challenging surgery
Keywords:Liposarcoma, Retroperitoneum, Chemotherapy, Radiotherapy
Retroperitoneal liposarcoma is a rare malignant disease with a high rate of recurrence. Retroperitoneal liposarcoma is usually asymptomatic until the liposarcoma is large enough to compress the surrounding organs and usually presented with compressive symptoms. Main modality of the treatment is surgery both in primary and recurrence cases. Even with complete removal of the liposarcoma, local recurrence rate is very high. Till now, there is currently no evidence that chemotherapy or radiotherapy improve survival rates. Successful complete resection of recurrent retroperitoneal liposarcoma is the sole chance of cure and may increase the 5-year survival rate. In recurrent case, it is challenging for the operating surgeon because of the altered anatomy, adherent to adjacent organs and large vessels and the huge size of the recurrent tumour. The aim of the present study is to report a giant recurrent retroperitoneal liposarcoma and its challenging surgical management.
Devita VT Jr., Lawrence TS, Rosenberg SA. Cancer Principles & Practice of Oncology, 11th edition. Philadelphia: 2019: 1427-1430.
Mendenhall WM, Zlotecki RA, Hochwald SN, Hemming AW, Grobmyer SR, Cance WG. Retroperitoneal soft tissue sarcoma. Cancer. 2005;104:669-75.
Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. World Health Organization Classification of Tumours of Soft Tissue and Bones, 4th ed. Lyon: IARC Press; 2013.
Bradley JC, Caplan R. Giant retroperitoneal sarcoma: A case report and review of the management of retroperitoneal sarcomas. Am Surg. 2002;68:52-6.
Fabre-Guillevin E, Coindre JM, Somerhausen NS, Bonichon F, Stoeckle E, Bui NB. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas. Cancer. 2006;106:2725-33.
Neuhaus SJ, Barry P, Clark MA, Hayes AJ, Fisher C, Thomas JM. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg. 2005;92:246-52.
Chang IY, Herts BR. Retroperitoneal liposarcoma. J Urol. 2013;189:1093-4.
Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358-71.
Nijhuis PH, Sars PR, Plaat BE, Molenaar WM, Sluiter WJ, Hoekstra HJ. Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas. Ann Surg Oncol. 2000;7:535-43.
Milone M, Pezzullo LS, Salvatore G, PezzulloEsposito I, Milone F. Management of high-grade retroperi-tonealliposarcomas: personal experience. Updates Surg. 2011;63:119-24.
Lee SY, Goh BK, Teo MC, Chew MH, Chow PK, Wong WK, et al. Retroperitoneal liposarcomas: the experience of a tertiary Asian center. World J Surg Oncol. 2011;9:12.
Bautista N, Su W, O'Connell TX. Retroperitoneal soft-tissue sarcomas: Prognosis and treatment of primary and recurrent disease. Am Surg. 2000;66:832-6.
Zhang WD, Liu DR, Que RS, Zhou C, Zhan CN. Management of retroperitonealliposarcoma: A case report and review of the literature. Oncol Letters. 2015;10:405-9.
Perez EA, Gutierrez JC, Moffat FL Jr. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol. 2007;14:1114-22.